Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Endocrinology  |  Family Medicine  |  Podiatry

Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetic Foot Ulcers Clinical Trials

A listing of Diabetic Foot Ulcers medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (94) clinical trials


The primary objective of this study is to determine the number of successful complete wound closures within 12 weeks of treatment with MIRODERM Fenestrated Biological Wound Matrix. Some secondary objectives of this study include documenting the time course of wound healing and assessing changes in quality of life. The primary ...

Phase N/A

Evaluation of Safety of Low Level Laser Device Treatment in Chronic Wounds

This is a randomized, double blind, placebo-controlled study to evaluate the safety of the low level laser MC-8XL device treatment in subjects with an unsuccessfully treated Diabetic Foot Ulcer (DFU) that has been present for at least 3 months. Eligible subjects will be randomized to either Treatment group or Control ...

Phase N/A

Effect of miR-200b on Diabetic Wounds

The study is designed as a 14 week prospective observational study where patients with diabetic wounds visiting the Ohio State University Comprehensive Wound Center (CWC) will be enrolled. Patients enrolled will be followed for 14 weeks including 4 study visits, initial visit (week 0), study visit 2 (week 2), study ...

Phase N/A

Wound Healing Endpoint and Recurrence

This prospective pilot study is to enroll patients with clinically-defined infected wounds. Patients enrolled in the study will be followed for 16 weeks for wound closure (Phase A), and will then begin Phase B. Wounds will be subjected to Standard of Care (SoC) followed by all Comprehensive Wound Center (CWC) ...

Phase N/A

DermACELL AWM in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers

This clinical evaluation with DermACELL AWM will explore its use in the treatment of complex soft tissue defects involving muscle, fascia, tendon, or bone exposure (Wagner Classification 3 and 4). A total of 50 subjects will be treated with DermACELL AWM in the operating room for coverage of deep soft ...

Phase N/A

ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers

This study is designed as a prospective, open-label trial focused on assessing the safety and tolerability of ExpressGraft-C9T1 skin tissue in the treatment of diabetic foot ulcers (DFU). Because the focus is on safety rather than efficacy, a standard of care comparator is not included in this first-in-human study. Targeted ...


RECCORD (Recording Courses of Vascular Diseases) Registry

For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631

Phase N/A

Foot Assessment in People With Diabetes: A Quantitative Diagnostic Approach

The purpose of this research observational cohort study is to investigate the applicability of using biomechanical assessment in predicting the ulceration incidence in patients with diabetic neuropathic feet. The proposed study will lead to the development of further stratification of high-risk patients into subcategories indicating the vulnerability of tissue to ...

Phase N/A

A Study of Granexin Gel to Treat Diabetic Foot Ulcer

DFU patients will undergo a one week screening period and those with changes in ulcer size of less than 30% will be eligible for randomization providing all other criteria are met. Participants enrolled in the study will receive treatment based on randomization into 1 of 2 treatment arms for up ...


Evaluate the Efficacy and Safety of WH-1 Ointment for the Treatment of Chronic Diabetic Foot Ulcers

This trial is designed as a randomized, evaluator blinded, active-controlled, multi-center study comparing the efficacy and safety of WH-1 ointment and Aquacel Hydrofiber dressing in the treatment of diabetic foot ulcers. Independent evaluators who blinded to subjects' treatment will evaluate whether the wound has healed. Eligible subjects will be randomized ...